These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2552566)
1. [Diagnostic strategy in liver and pancreatic tumors: imaging diagnosis using MRT]. Langkowski JH Rontgenblatter; 1989 Sep; 42(9):400-5. PubMed ID: 2552566 [TBL] [Abstract][Full Text] [Related]
2. [Fat-suppressed MR imaging sequences in the diagnosis of liver and pancreatic neoplasms at 1.5 tesla]. Hagspiel KD; Neidl KF; Hauser M; Duewell S; Marincek B Rofo; 1994 Mar; 160(3):235-42. PubMed ID: 8136477 [TBL] [Abstract][Full Text] [Related]
3. [Methodologic variants on rapid MR imaging of the liver]. Langkowski JH; Heller M; Maas R; Kooijman H; Bücheler E Rofo; 1987 Nov; 147(5):546-9. PubMed ID: 2825292 [TBL] [Abstract][Full Text] [Related]
4. MR differentiation of hepatic haemangioma and hepatocellular carcinoma: value of delayed-phase Gd-DTPA enhanced images. Okada Y; Itai Y; Ohtomo K; Kokubo T; Yoshida H; Sasaki Y Rofo; 1991 Jun; 154(6):621-7. PubMed ID: 1648765 [TBL] [Abstract][Full Text] [Related]
5. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951 [TBL] [Abstract][Full Text] [Related]
6. [Differentiation of focal liver lesions using contrast-enhanced MRT]. Heintz P; Ehrenheim C Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver]. Zhang HM; Ouyang H; Zhou CW Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of the spleen and pancreas. Brown ED; Semelka RC Top Magn Reson Imaging; 1995; 7(2):82-9. PubMed ID: 7772373 [TBL] [Abstract][Full Text] [Related]
15. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141 [TBL] [Abstract][Full Text] [Related]
16. [MR imaging of liver metastasis using Gd-EOB-DTPA]. Kuwatsuru R Gan To Kagaku Ryoho; 2009 Aug; 36(8):1234-41. PubMed ID: 19692760 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study. Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149 [TBL] [Abstract][Full Text] [Related]
18. [MRI in the differential diagnosis of liver focal lesions]. Negru D; Fotea V; Grigoraş M; Moisii L; Daniil C Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):548-54. PubMed ID: 17571543 [TBL] [Abstract][Full Text] [Related]
19. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful? Chung JJ; Kim MJ; Kim KW J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954 [TBL] [Abstract][Full Text] [Related]
20. [MR imaging during arteriography (MR arteriography) in the detection of hepatocellular carcinoma]. Fujita T; Choji T; Ito K; Hatanaka M; Suga K; Yoneshiro S; Matsumoto T; Nakada T; Nakanishi T Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jun; 53(6):716-8. PubMed ID: 8393187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]